Know What's Happening in Life

Johns Hopkins Leads $24M Multinational Consortium to Find Hepatitis B Cure

Johns Hopkins Medicine is heading a five‑year, $24 million NIH‑funded Hepatitis B and HIV Cure Consortium that brings together research teams from the United States, Brazil, India, Senegal and Uganda. The first year will enroll 450 participants co‑infected with HIV and chronic hepatitis B and 225 with hepatitis B alone, creating a multinational specimen repository. Seven specialized cores—virology, shared resources, multiomics, biostats, clinical, immunology and translational—will generate biomarkers, analyze viral‑host interactions and test cure strategies. The effort also includes training early‑stage investigators to sustain a global cure pipeline.